MedTrace Logo

Visual Perceptual Learning for the Treatment of Visual Field Defect

NCT04102605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-06-08

No results posted yet for this study

Summary

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain damage. Half of participants will receive visual perceptual training using the Nunap Vision, while the other half will receive sham training using the Nunap Vision-C.

Conditions

  • Visual Fields Hemianopsia
  • Hemianopsia, Homonymous

Interventions

DEVICE

Nunap Vision

Participants receive visual perceptual training using the Nunap Vision software

DEVICE

Nunap Vision-C

Participants receive sham training using the Nunap Vision-C software

Sponsors & Collaborators

  • Nunaps Inc

    lead INDUSTRY

Principal Investigators

  • Sun U. Kwon, MD, PhD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-17
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04102605 on ClinicalTrials.gov